scispace - formally typeset
X

Xiaodong Ma

Researcher at Dalian Medical University

Publications -  140
Citations -  2459

Xiaodong Ma is an academic researcher from Dalian Medical University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 22, co-authored 116 publications receiving 1569 citations.

Papers
More filters
Journal ArticleDOI

Therapeutic Versatility of Resveratrol Derivatives.

TL;DR: The chemical structure and the therapeutic versatility of resveratrol derivatives are summarized to provide the related structure activity relationship reference for their practical applications.
Journal ArticleDOI

Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.

TL;DR: The data showed that dioscin is a novel and potent FXR agonist to suppress inflammation and oxidative stress against Dox-induced nephrotoxicity.
Journal ArticleDOI

Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer.

TL;DR: This review on the small-molecule EGFR T790M inhibitors, along with their discovery strategies, will assist in the design of future T790m-containing EGFR inhibitors with high levels of selectivity over WT EGFR, broad kinase selectivity, and desirable physicochemical properties.
Journal ArticleDOI

Neuroprotective effect of phosphocreatine on oxidative stress and mitochondrial dysfunction induced apoptosis in vitro and in vivo: Involvement of dual PI3K/Akt and Nrf2/HO-1 pathways.

TL;DR: The neuroprotective effects of PCr in vitro and in vivo rely on normalizing mitochondrial function and reducing oxidative stress via Akt mediated Nrf2/HO‐1 pathway, suggesting that PCr may be a novel therapeutic candidate for the treatment of diabetes‐associated neurodegenerative diseases.
Journal ArticleDOI

Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation.

TL;DR: Dioscin showed protective effects against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, renal fibrosis, lipid metabolism and inflammation, which should be considered as one candidate to treat renal injury in the future.